Markets:

Overview

News

Currencies

International

Treasuries

iShares Biotechnology ETF (NQ:IBB)

206.40 +1.11 (+0.54%)

Delayed Quote Updated: 12:25 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

28 29 Next >

CPI-Market Impact Now And Later? ↗

August 10, 2023

A discussion about inflation, bonds, calendar ranges, and places to park your money

Via Talk Markets

Topics Bonds Economy

Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss ↗

August 10, 2023

The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline.

Via Benzinga

Topics ETFs Economy

5 Magnificent ETFs to Buy Hand Over Fist for the Second Half of 2023 ↗

August 08, 2023

These exchange-traded funds (ETFs) offer low or ultralow net expense ratios and are perfectly positioned to help investors grow their wealth.

Via The Motley Fool

The July 6-Month Calendar Range SPY QQQ IWM TLT ↗

July 26, 2023

Looking at the SPY chart, we have had 7 trading days above the range high. However, to date, SPY has not really taken off from that level and sits more in consolidation mode.

Via Talk Markets

3 Top ETFs to Buy Right Now ↗

July 24, 2023

These three exchange-traded funds could be winning plays for patient investors.

Via The Motley Fool

Rising Stars, Falling Trends: July's Industry ETF Winners And Losers ↗

July 31, 2023

Via Benzinga

Now That The July 6-Month Calendar Range Is Set ↗

July 24, 2023

As this week begins with a test of the July 6-month calendar range high, should that level break down, it could mean a substantially wide trading range in store for the small caps.

Via Talk Markets

On A Winning Streak! Many Market Signs Appear More Bullish ↗

July 23, 2023

This past week corporate earnings announcements picked up speed. You may recall that we mentioned the large money center Banks had announced the week before. If you did not read last week’s issue, you...

Via Talk Markets

Major Sector ETFs Re-Set In July-Blueprint ↗

July 17, 2023

Retail XRT is in a Distribution phase and has to clear the 200-WMA and calendar range high at 67.42. A move under 63.40 would be weak.

Via Talk Markets

Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗

July 17, 2023

Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%.

Via Talk Markets

Biotech Blues: Stay Balanced Through July Earnings Season ↗

July 05, 2023

Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts.

Via Talk Markets

Moderna: Declining Performance And Relative Weakness

June 30, 2023

Moderna's value has declined by over 75% from its peak as the world moves on from the COVID-19 pandemic, leading to concerns about its investment appeal.

Via MarketBeat

Topics ETFs

Biotech And Healthcare Stocks Lagging ↗

June 21, 2023

Healthcare is a laggard with XLV down YTD but UNH is still a core position.

Via Talk Markets

Is the Biotech Industry (IBB) Poised For A Major Breakout?

June 12, 2023

The current consolidation in the IBB signals a potential breakout might be looming as key moving averages have converged within a contracted price range.

Via MarketBeat

Topics ETFs

Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption? ↗

May 30, 2023

A steady rotation out of biotech and healthcare stocks into the Nasdaq-100 large-cap tech stocks can be unnerving for portfolio managers.

Via Talk Markets

3 Biotech Stocks to Avoid Like the Plague ↗

May 23, 2023

Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs.

Via InvestorPlace

Sunnier Skies This Past Week, But Will It Last? ↗

May 21, 2023

The stock market rallied out of a long sideway consolidation pattern and made a new year-to-date high as well as a positive 52-week period. The S&P 500 was up 1.71%, and the Nasdaq 100 was up 3.53% for...

Via Talk Markets

Technical And Fundamental Analysis On US Oil Fund ↗

May 15, 2023

Energy, gas, and oil are the underperformers this year and the main reason many call for deflation, recession, or at the very least, the end of accelerating inflation.

Via Talk Markets

Time To Play Small Cap Life Science Stocks ↗

May 15, 2023

The overall market sentiment has been hit hard by MACRO concerns. The dominating narrative is the Fed and the Debt Ceiling.

Via Talk Markets

Biotech ETFs Pop On M&A Resurgence ↗

May 10, 2023

The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A).

Via Talk Markets

Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector ↗

May 01, 2023

A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...

Via Talk Markets

Healthcare Sector Update: MedTech Trending Up ↗

April 20, 2023

Earnings from major device companies and large-cap biopharma over the next two weeks will help us ascertain risks for the market.

Via Talk Markets

The Economic Modern Family & the MOST IMPORTANT Data Ever ↗

April 16, 2023

Bitcoin (BTC), defies all the talking heads. While Sister Semiconductors is our Wonder Woman, Bitcoin is our Rebel with a Cause. BTC closed the week at new yearly highs!

Via Talk Markets

Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention ↗

April 13, 2023

U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of...

Via Benzinga

Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules ↗

April 13, 2023

A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug.

Via Benzinga

Trillions In Biotech Stock Gains Trace Back To This Financier ↗

April 13, 2023

Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider.

Via Investor's Business Daily

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗

April 12, 2023

New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this...

Via Benzinga

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗

April 11, 2023

In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating...

Via Benzinga

April Is Busting Out For Healthcare And Biotech ↗

April 10, 2023

Last week was a good week for healthcare stocks and most large cap biopharmaceutical stocks resumed an upward trend.

Via Talk Markets

FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits ↗

April 06, 2023

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.